News Search Results
Jan 07, 2026, 07:00 ET Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
Series B Co-led by New Investors Amplitude Ventures and ICGMTX-474 Global Phase 2a study Initiated in Systemic Sclerosis (SSc)MTX-463 Global Phase 2a Study in Idiopathic Pulmonary Fibrosis (IPF) Enrolling & Partnered
More news about: Mediar Therapeutics
Jan 06, 2026, 16:30 ET ASUR Announces Total Passenger Traffic for December 2025
Mexican Bolsa, where it trades under the symbol ASUR, and on the NYSE in the U.S., where it trades under the symbol ASR. One ADS represents ten (10) series B shares. For more information, visit
More news about: Grupo Aeroportuario del Sureste, S.A.B. de C.V.
Jan 06, 2026, 10:00 ET JOURNAL OF TRANSLATIONAL MEDICINE PUBLISHES PAPER HIGHLIGHTING POTENTIAL OF THE ELEPHAS LIVE™ PLATFORM TO TRANSFORM IMMUNOTHERAPY OUTCOMES
transform cancer care."This publication coincides with Elephas' international expansion and builds on the momentum of its recent $42 million Series B2 financing. In addition, at the recent SITC Annual Meeting, Elephas unveiled new data demonstrating a strong correlation between ex vivo cytokine
More news about: Elephas
Jan 06, 2026, 09:00 ET GSME Secures $35M Series B Funding
Calif., Jan. 6, 2026 /PRNewswire/ -- GS Microelectronics U.S., Inc. (GSME) today announced a $35 million Series B round led by Maverick Silicon to expand its semiconductor services platform across advanced packaging, design enablement, and supply chain visibility.
More news about: GS Microelectronics
Jan 06, 2026, 07:40 ET Imagine Pediatrics Accelerates Growth into New States and Commercial Health Plan Market to Expand Access and Improve Outcomes for Children with Special Health Care Needs
Series B funding round of $67M in September, Imagine Pediatrics is increasing its impact, reaching tens of thousands more children and is on pace for continued
More news about: Imagine Pediatrics
Jan 05, 2026, 11:22 ET PNC Completes Acquisition of FirstBank
same award-winning experience our customers have come to expect."In connection with the acquisition, shares of FirstBank Holding Company's Series B preferred stock that were issued and outstanding immediately prior to the legal close are automatically being converted into a newly created series
More news about: The PNC Financial Services Group, Inc.
Jan 05, 2026, 11:09 ET PNC Declares Dividend of $1.70 on Common Stock
payable to shareholders of record as of the close of business on each related record date. The preferred stocks listed below (except for Preferred Series B) are each represented by 100 depositary shares:
More news about: The PNC Financial Services Group, Inc.
Jan 05, 2026, 09:00 ET Cambium Secures $100 Million Series B to Accelerate the Discovery and Scaling of Advanced Materials
2026 /PRNewswire/ -- Cambium, a pioneer in advanced materials for defense, aerospace, and other high-performance sectors, announced a $100 million Series B financing led by 8VC, with participation from MVP Ventures, Lockheed Martin Ventures, GSBackers, Veteran Ventures Capital, J17 Ventures, Vanderbilt
More news about: Cambium Biomaterials, Inc
Dec 30, 2025, 20:14 ET Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange
billion. Qiming Venture Partners is one of Insilico Medicine's most important institutional investors. Qiming Venture Partners led the Company's Series B financing round in 2019 and continued its support in subsequent Series C and D rounds, with an about 7 percent stake in Insilico Medicine before its
More news about: Qiming Venture Partners
Dec 30, 2025, 19:50 ET Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange
billion. Qiming Venture Partners is one of Insilico Medicine's most important institutional investors. Qiming Venture Partners led the Company's Series B financing round in 2019 and continued its support in subsequent Series C and D rounds, with an about 7 percent stake in Insilico Medicine before its
More news about: Qiming Venture Partners
Dec 26, 2025, 12:02 ET MemryX Unveils MX4 Roadmap: Enabling Distributed, Asynchronous Dataflow for Highly Efficient Data Center AI
production-proven "at-memory" dataflow architecture that delivers superior efficiency for edge and upcoming data center applications. Backed by $44M in Series B funding from investors including HarbourVest, NEOM Investment Fund (NIF), Arm IoT Fund, eLab Ventures, M Ventures, and Motus Ventures, MemryX is driving
More news about: MemryX
Dec 26, 2025, 11:30 ET Intelligent Living Application Group Inc. Announces 1-for-10 Share Consolidation (Reverse Stock Split)
shares outstanding will be approximately 200,000 with a par value of $0.001. The current pre-split number of Series B preferred shares outstanding is 10,000,000 with a par value of $0.0001 and the post-split number of Series B preferred shares outstanding will be approximately 1,000,000 with a par value of $0.001. The
More news about: Intelligent Living Application Group Inc.
Dec 22, 2025, 17:00 ET Intelligent Living Application Group Inc. Announces First Half 2025 Unaudited Financial Results
pursuant to the Articles of Association of the Company, designated 10,000,000 Preferred Shares of the Company as series B preferred shares of the Company, par value US$0.0001 each ("Series B Preferred Shares" or the "Subject Shares") and every holder of the Subject Shares present in person (or being a
More news about: Intelligent Living Application Group, Inc.
Dec 19, 2025, 16:10 ET cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance
Minnesota, with the ability to ship directly to additional states where permitted.At the end of September 2025, cbdMD completed $1.7 million in Series B Convertible Preferred equity financing, generating $1.5 million in net proceeds to support working capital and strengthen net book value.The
More news about: cbdMD, Inc.
Dec 19, 2025, 15:01 ET cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement
subject to certain anti-dilution protection provisions, with rights and preferences substantially the same as the Company's issued and outstanding Series B Convertible Preferred Stock.
More news about: cbdMD, Inc.
Dec 18, 2025, 11:00 ET Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering
powering every engineering team, worldwide."Neural Concept's Series C marks the company's latest funding milestone following its $27 million Series B in 2024.About Neural Concept Founded in 2019, Neural Concept provides the leading AI-first engineering platform for product development.
More news about: Neural Concept
Dec 18, 2025, 10:02 ET Industrious Ventures Announces Appointment of Matt White, EVP & CFO of Linde, to Stoke Space's Board of Directors
Steve Angel, Chairman of Linde and long-time advisor to Industrious Ventures, who has represented the firm on Stoke's board since it led the company's Series B in October 2023.White brings more than two decades of leadership in global industrial and engineering companies. As EVP and CFO of Linde, the
More news about: Industrious Ventures
Dec 17, 2025, 11:30 ET Tokenfolio ramps up their institutional arm with Carta appointment to meet increasing institutional demand
Valley and are currently focusing on investing early in what will become the top private market names of tomorrow. Tokenfolio typically invests in Series B through pre-IPO.Their portfolio includes some of the top tech companies in AI infrastructure, AI robotics, and deep tech AI – for many of these,
More news about: Tokenfolio
Dec 17, 2025, 08:00 ET 2025 in Review: South Korea's Leading AI Innovator Marks Breakout Year After U.S. Launch
Upstage raised $45 million earlier this year in a Series B bridge round, bringing total funding to $157 million, to expand its growth in the U.S. Notably, the AI company secured funding from Amazon Web Services
More news about: Upstage AI
Dec 16, 2025, 11:00 ET RedotPay Raises US$107M in Series B to Drive Stablecoin Payments Adoption Globally
RedotPay, a global stablecoin-based payment fintech, today announced the successful completion of its US$107 million Series B round, bringing the total capital raised in 2025 to US$194 million. This oversubscribed round is a clear signal of investor confidence in RedotPay's
More news about: RedotPay
Dec 16, 2025, 09:01 ET Looma Raises $13 Million to Expand In-Store Retail Media Network; Launches into 600 Kroger Stores Amid Surging Demand
Dec. 16, 2025 /PRNewswire/ -- Looma, a leading in-store retail media platform, today announced that it has raised $10 million in Series B funding led by Staley Capital, alongside a $3 million credit facility from Silicon Valley Bank, a division of First Citizens Bank, bringing its total
More news about: Looma
Dec 16, 2025, 09:00 ET Adaptive Security Raises $81 Million Series B to Stop AI-Powered Cyber Threats
Adaptive Security today announced it has raised an $81 million Series B funding round led by Bain Capital Ventures, with participation from NVentures (NVIDIA's venture capital arm), OpenAI Startup Fund, Andreessen Horowitz
More news about: Adaptive Security
Dec 16, 2025, 08:00 ET TSC Alliance Endowment Fund Invests in Aeovian Pharmaceuticals to Advance Development of an mTORC1 Selective Inhibitor for Tuberous Sclerosis Complex
/PRNewswire/ -- The TSC Alliance Endowment Fund, a supporting organization of the TSC Alliance, has invested in Aeovian Pharmaceuticals as part of their Series B financing in support of their Phase 2 trial of AV078, a first-in-class CNS-penetrant selective mTORC1 inhibitor in tuberous sclerosis complex (TSC).
More news about: TSC Alliance
Dec 15, 2025, 12:00 ET Axion Raises $37M Series B to Power the Future of American Manufacturing
Dec. 15, 2025 /PRNewswire/ -- Axion, the pioneering AI platform for manufacturing product quality, today announced a $37 million Series B funding round led by Salesforce Ventures with participation from Bessemer Venture Partners, Schneider Electric Ventures, and other existing investors.
More news about: Axion Ray
Dec 12, 2025, 07:30 ET Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline
dermatology company developing first-in-class Multi-Target Therapeutics®, today announced the close of its $25 million, twice-oversubscribed Series B financing. Proceeds will fund the Phase 2b global clinical trial of Alphyn's lead drug candidate, Zabalafin Hydrogel, for atopic dermatitis (AD),
More news about: Alphyn Biologics, Inc.